Tengku Ampuan Afzan Hospital is a hospital in Kuantan, Pahang, Malaysia. The hospital began operation in 1983.

During the past decade, Hospital Tengku Ampuan Afzan conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 14 clinical trials were completed, i.e. on average, 35.9% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 11 clinical trials were completed. i.e. 55% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Tengku Ampuan Afzan" #1 sponsor was "Boehringer Ingelheim" with 7 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Tengku Ampuan Afzan" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator, "Hospital Melaka, Melaka" with 2 trials as a collaborator and "Hospital Queen Elizabeth, Malaysia" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Tengku Ampuan Afzan" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Crohn's Disease" (3 trials), "Anosmia" (2 trials), "Arthritis, Rheumatoid" (2 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Hospital Tengku Ampuan Afzan" in a lesser frequency.

Most popular intervention types in "Hospital Tengku Ampuan Afzan" are "Drug" (37 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (4 trials), "Pemetrexed" (4 trials), "Amivantamab" (3 trials) and "Lazertinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Tengku Ampuan Afzan" are 43 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Tengku Ampuan Afzan". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Hospital Tengku Ampuan Afzan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Tengku Ampuan Afzan, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".